1
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth DEdition, Text ERevision (DSM-IV-TR).
APA, 2000.
2
Larson, K, Russ, SA, Kahn, RS, Halfon, N. Patterns of comorbidity, functioning, and service use for US children with ADHD, 2007. Pediatrics
2011; 127: 462–70.
3
Simonoff, E, Pickles, A, Charman, T, Chandler, S, Loucas, T, Baird, G. Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample. J Am Acad Child Adolesc Psychiatry
2008; 47: 921–9.
4
Faraone, SV, Buitelaar, J. Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis. Eur Child Adolesc Psychiatry
2010; 19: 353–64.
5
Cortese, S, Castelnau, P, Morcillo, C, Roux, S, Bonnet-Brilhault, F. Psychostimulants for ADHD-like symptoms in individuals with autism spectrum disorders. Expert Rev Neurother
2012; 12: 461–73.
6
van de Loo-Neus, GH, Rommelse, N, Buitelaar, JK. To stop or not to stop? How long should medication treatment of attention-deficit hyperactivity disorder be extended?
Eur Neuropsychopharmacol
2011; 21: 584–99.
7
Zetterqvist, J, Asherson, P, Halldner, L, Langstrom, N, Larsson, H. Stimulant and nonstimulant attention deficit/hyperactivity disorder drug use: total population study of trends and discontinuation patterns 2006–2009. Acta Psychiatr Scand
2013; 128:70–7.
8
Lofthouse, N, Arnold, LE, Hersch, S, Hurt, E, DeBeus, R. A review of neurofeedback treatment for pediatric ADHD. J Atten Disord
2012; 16: 351–72.
9
Holtmann, M, Steiner, S, Hohmann, S, Poustka, L, Banaschewski, T, Bolte, S. Neurofeedback in autism spectrum disorders. Dev Med Child Neurol
2011; 53: 986–93.
10
Loo, SK, Makeig, S. Clinical utility of EEG in attention-deficit/hyperactivity disorder: a research update. Neurotherapeutics
2012; 9: 569–87.
11
Snyder, SM, Hall, JR. A meta-analysis of quantitative EEG power associated with attention-deficit hyperactivity disorder. J Clin Neurophysiol
2006; 23: 440–55.
12
Banaschewski, T, Brandeis, D. Annotation: what electrical brain activity tells us about brain function that other techniques cannot tell us – a child psychiatric perspective. J Child Psychol Psychiatry
2007; 48: 415–35.
13
Roth, SR, Sterman, MB, Clemente, CD. Comparison of EEG correlates of reinforcement, internal inhibition and sleep. Electroencephalogr Clin Neurophysiol
1967; 23: 509–20.
14
Arns, M, de Ridder, S, Strehl, U, Breteler, M, Coenen, A. Efficacy of neurofeedback treatment in ADHD: the effects on inattention, impulsivity and hyperactivity: a meta-analysis. Clin EEG Neurosci
2009; 40: 180–9.
15
Sonuga-Barke, EJ, Brandeis, D, Cortese, S, Daley, D, Ferrin, M, Holtmann, M, et al. Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. Am J Psychiatry
2013; 170: 275–89.
16
Meisel, V, Servera, M, Garcia-Banda, G, Cardo, E, Moreno, I. Neurofeedback and standard pharmacological intervention in ADHD: a randomized controlled trial with six-month follow-up. Biol Psychol
2013; 94: 12–21.
17
Gevensleben, H, Holl, B, Albrecht, B, Schlamp, D, Kratz, O, Studer, P, et al. Neurofeedback training in children with ADHD: 6-month follow-up of a randomised controlled trial. Eur Child Adolesc Psychiatry
2010; 19: 715–24.
18
Steiner, NJ, Frenette, EC, Rene, KM, Brennan, RT, Perrin, EC. In-school neurofeedback training for ADHD: sustained improvements from a randomized control trial. Pediatrics
2014; 133: 483–92.
19
Duric, NS, Assmus, J, Gundersen, D, Elgen, IB. Neurofeedback for the treatment of children and adolescents with ADHD: a randomized and controlled clinical trial using parental reports. BMC Psychiatry
2012; 12: 107.
20
Wechsler, D. Wechsler Intelligence Scale for Children.
The Psychological Corporation, 1991.
21
Wechsler, D. Wechsler Adult Intelligence Scale.
The Psychological Corporation, 1997.
22
Kooij, JJS. ADHD in Adults. Introduction to Diagnosis and Treatment [in Dutch]. Swets & Zeitlinget, 2002.
23
Sheehan, DV, Lecrubier, Y, Sheehan, KH, Janavs, J, Weiller, E, Keskiner, A, et al. The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P and its reliability. Eur Psychiatry
1997; 12: 232–41.
24
Sheehan, DV, Lecrubier, Y, Sheehan, KH, Amorim, P, Janavs, J, Weiller, E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry
1998; 59 (suppl 20): 22–33; quiz 4–57.
26
Faul, F, Erdefelder, E, Lang, AG, Buchner, A. G*Power 3: a flexible statistical power analysis program for the social, behavioral and biomedical sciences. Behav Res Methods
2007; 39: 175–91.
27
Schulz, KF, Altman, DG, Moher, D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMC Med
2010; 8: 18.
28
Vink, M, Van Wamel, A. Landelijk Basisprogramma: ADHD bij kinderen en jeugdigen [Dutch Basic Programme: ADHD for Children and Adolescents]. Trimbos instituut, Netherlands Institute of Mental Health and Addiction, 2007.
29
Lubar, JF. Neurofeedback for the management of attention deficit disorders. In Biofeedback: A Practitioner's Guide (eds Schwartz, MS, Andrasik, F): 409–37. The Guilford Press, 2003.
30
Bink, M, van Nieuwenhuizen, C, Popma, A, Bongers, IL, van Boxtel, GJ. Neurocognitive effects of neurofeedback in adolescents with ADHD: a randomized controlled trial. J Clin Psychiatry
2014; 75: 535–42.
31
Kooij, JJS, Buitelaar, JK, van den Oord, EJ, Furer, JW, Rijnders, CA, Hodiamont, PP. Internal and external validity of attention-deficit hyperactivity disorder in a population-based sample of adults. Psychol Med
2005; 35: 817–27.
32
Kooij, JJS, Boonstra, AM, Swinkels, SHN, Bekker, EM, de Noord, I, Buitelaar, JK. Reliability, validity, and utility of instruments for self-report and informant report concerning symptoms of ADHD in adult patients. J Atten Disord
2008; 11: 445–58.
33
DuPaul, GJ, Power, TJ, Anagnostopoulos, AD, Reid, R. ADHD Rating Scale-IV. Checklists, Norms Cand Clinical Interpretation.
The Guilford Press, 1998.
34
Loo, SK, Barkley, RA. Clinical utility of EEG in attention deficit hyperactivity disorder. Appl Neuropsychol
2005; 12: 64–76.
35
van Dongen-Boomsma, M, Vollebregt, MA, Slaats-Willemse, D, Buitelaar, JK. A randomized placebo-controlled trial of electroencephalographic (EEG) neurofeedback in children with attention-deficit/hyperactivity disorder. J Clin Psychiatry
2013; 74: 821–7.
36
Achenbach, TM. Integrative guide for the 1991 CBCL/4-18, YSR and TRF profiles.
University of Vermont Department of Psychiatry, 1991.
37
Brickenkamp, R. D2 Attention and Concentration Test [in Dutch]. Hogrefe, 2007.
38
Hammes, JGW. STROOP Kleur-Woord Test. Handleiding [STROOP Color-Word Test. Manual]. Swets and Zeitlinger, 1978.
39
Stroop, JR. Studies of interference in serial verbal reactions. J Exp Psychol
1935; 18: 643–62.
40
Culbertson, WC, Zilmer, EA. Tower of London - Drexel University (TOL DX TM).
Multi-Health Systems, 2005.
41
Achenbach, TM. Integrative Guide for the 1991 CBCL/4-18, YSR and TRF Profiles.
University of Vermont Department of Psychiatry, 1991.
42
Baron-Cohen, S, Hoekstra, RA, Knickmeyer, R, Wheelwright, S. The Autism-Spectrum Quotient (AQ) – adolescent version. J Autism Dev Disord
2006; 36: 343–50.
43
Bink, M, van Nieuwenhuizen, C, Popma, A, Bongers, IL, van Boxtel, GJ. Behavioral effects of neurofeedback in adolescents with ADHD: a randomized controlled trial. Eur Child Adolesc Psychiatry
2015; 24: 1035–48.
44
Vollebregt, MA, van Dongen-Boomsma, M, Buitelaar, JK, Slaats-Willemse, D. Does EEG-neurofeedback improve neurocognitive functioning in children with attention-deficit/hyperactivity disorder? A systematic review and a double-blind placebo-controlled study. J Child Psychol Psychiatry
2014; 55: 460–72.
45
Bink, M, van Boxtel, GJ, Popma, A, Bongers, IL, Denissen, AJ, van Nieuwenhuizen, C. EEG theta and beta power spectra in adolescents with ADHD versus adolescents with ASD + ADHD. Eur Child Adolesc Psychiatry
2015; 24: 873–86.
46
Cortese, S. The neurobiology and genetics of attention-deficit/hyperactivity disorder (ADHD): what every clinician should know. Eur J Paediatr Neurol
2012; 16: 422–33.
47
Clarke, AR, Barry, RJ, Bond, D, McCarthy, R, Selikowitz, M. Effects of stimulant medications on the EEG of children with attention-deficit/hyperactivity disorder. Psychopharmacology (Berl)
2002; 164: 277–84.
48
Clarke, AR, Barry, RJ, McCarthy, R, Selikowitz, M, Brown, CR, Croft, RJ. Effects of stimulant medications on the EEG of children with Attention-Deficit/Hyperactivity Disorder Predominantly Inattentive type. Int J Psychophysiol
2003; 47: 129–37.
49
Hermens, DF, Williams, LM, Clarke, S, Kohn, M, Cooper, N, Gordon, E. Responses to methylphenidate in adolescent AD/HD: evidence from concurrently recorded autonomic (EDA) and central (EEG and ERP) measures. Int J Psychophysiol
2005; 58: 21–33.
50
Arnold, LE, Lofthouse, N, Hersch, S, Pan, X, Hurt, E, Bates, B, et al. EEG neurofeedback for ADHD: double-blind sham-controlled randomized pilot feasibility trial. J Atten Disord
2013; 17: 410–19.
1-year follow-up of neurofeedback treatment in adolescents with attention-deficit hyperactivity disorder: randomised controlled trial
eLetters
No eLetters have been published for this article.